WuXi AppTec Leads Strategic Funding In US Healthcare AI Firm Insilico Medicine

Login to View

Shanghai-based pharmaceutical and medical device firm WuXi AppTec has led a strategic funding round in Insilico Medicine, a Baltimore-based artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in